Bangkok Genomics Innovation PCL

Bangkok Genomics Innovation PCL EBITDA

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Bangkok Genomics Innovation PCL (BKGI.BK) as of Oct 31, 2026 is 42.40 M THB. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was 59.04 M THB — a change of -28.18% (lower).

EBITDA

42.40 MTHB

YoY

-28.18%

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Bangkok Genomics Innovation PCL is 2025 42.40 M THB. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Bangkok Genomics Innovation PCL was 2024 59.04 M THB. It decreases by -28.18% lower compared to the previous year.

The Bangkok Genomics Innovation PCL EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA
Date
EBITDA
Jan 1, 2018
-13.85 M THB
Jan 1, 2019
12.69 M THB
Jan 1, 2020
13.80 M THB
Jan 1, 2021
106.62 M THB
Jan 1, 2022
83.23 M THB
Jan 1, 2023
36.98 M THB
Jan 1, 2024
59.04 M THB
Jan 1, 2025
42.40 M THB
The Bangkok Genomics Innovation PCL EBITDA history
YEAREBITDAYoY
42.40 MTHB-28.18%
59.04 MTHB+59.65%
36.98 MTHB-55.57%
83.23 MTHB-21.94%
106.62 MTHB+672.42%
13.80 MTHB+8.74%
12.69 MTHB-191.63%
-13.85 MTHB—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Bangkok Genomics Innovation PCL Stock analysis

What does Bangkok Genomics Innovation PCL do? Bangkok Genomics Innovation PCL is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Bangkok Genomics Innovation PCL stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Bangkok Genomics Innovation PCL is 42.40 M THB in 2025.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Bangkok Genomics Innovation PCL changed from 59.04 M THB to 42.40 M THB, representing a -28.18% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) Bangkok Genomics Innovation PCL since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s THB is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s Bangkok Genomics Innovation PCL historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — Bangkok Genomics Innovation PCL

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Bangkok Genomics Innovation PCL